Illustration Port Of Marseille

Illustration Port Of Marseille

La Meridionale's Piana ferry and a Corsica Linea Ferry are docked facing the skyscraper of CMA-CGM's headquarters and the Tower La Marseillaise in Marseille, France, on April 13, 2024. Photo by Laurent Coust/ABACAPRESS.COM

  • Product Code
  • ILEA002573156
  • Registered date
  • 2024/4/13 00:00:00
  • Credit
  • Abaca Press / Kyodo News Images
  • Media source
  • Coust Laurent/ABACA
  • Media size
  • 8256 × 5504 pixel
  • Resolution
  • 300 dpi
  • Deployment size
  • 2.97(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    A giant fresco in homage to the rescuers of SOS Mediterranee - Marseille

    A giant fresco in homage to the rescuers of SOS Mediterranee - Marseille

    A giant mural in tribute to the rescuers of the SOS Méditerranée boat by artist Mahn Kloix replaces the emblematic Zinedine Zidane poster on a wall of the Corniche Kennedy in Marseille, France on November 18, 2024. The work pays tribute to the SOS Méditerranée rescuers and their humanitarian mission in the Mediterranean. Depicting a volunteer from the association observing the horizon with binoculars, this 12-metre-high fresco highlights the commitment of the NGO, which has been active since 2016 in rescuing migrants in distress at sea. Photo by Laurent Coust/ABACAPRESS.COM
      A giant fresco in homage to the rescuers of SOS Mediterranee - Marseille

      A giant fresco in homage to the rescuers of SOS Mediterranee - Marseille

      A giant mural in tribute to the rescuers of the SOS Méditerranée boat by artist Mahn Kloix replaces the emblematic Zinedine Zidane poster on a wall of the Corniche Kennedy in Marseille, France on November 18, 2024. The work pays tribute to the SOS Méditerranée rescuers and their humanitarian mission in the Mediterranean. Depicting a volunteer from the association observing the horizon with binoculars, this 12-metre-high fresco highlights the commitment of the NGO, which has been active since 2016 in rescuing migrants in distress at sea. Photo by Laurent Coust/ABACAPRESS.COM
        coust-doli

        coust-doli

        Illustration of Lysopaine boxe from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM
          coust-doli

          coust-doli

          Illustration of Doliprane boxes from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM
            coust-doli

            coust-doli

            Illustration of Doliprane boxe from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM
              coust-doli

              coust-doli

              Illustration of Doliprane boxe from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM
                coust-doli

                coust-doli

                Illustration of Doliprane boxes from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM
                  coust-doli

                  coust-doli

                  Illustration of Doliprane boxes from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM
                    coust-doli

                    coust-doli

                    Illustration of Doliprane boxes from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM
                      coust-doli

                      coust-doli

                      Illustration of Doliprane tablet from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM